Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arlene Chan

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Drugs|February 21, 2009
Antiangiogenic therapy for metastatic breast cancer: current status and future directionsArlene Chan
Therapeutic Advances in Medical Oncology|September 2, 2016
Neratinib in HER-2-positive breast cancer: results to date and clinical usefulnessArlene Chan
European Journal of Cancer (Oxford, England : 1990)|May 26, 2009
Capecitabine and vinorelbine in metastatic breast cancerArlene Chan, Mark Verrill
Breast (Edinburgh, Scotland)|August 11, 2014
Utilisation of primary and secondary G-CSF prophylaxis enables maintenance of optimal dose delivery of standard adjuvant chemotherapy for early breast cancer: an analysis of 1655 patientsArlene Chan, Scott McGregor, Wenbin Liang
The Oncologist|September 15, 2006
The role of capecitabine in first-line treatment for patients with metastatic breast cancerKaren Gelmon, Arlene Chan, Nadia Harbeck
Clinical Breast Cancer|May 11, 2023
Adjuvant Dose Dense Chemotherapy in Patients With Obesity: Short-Term Toxicities and Breast Cancer OutcomeChris Lomma, HuiJun Chih, Arlene Chan
Cancer Medicine|February 8, 2023
Prognostic role of immune environment in luminal B early breast cancerArlene Chan, Jespal Gill, HuiJun Chih, et al.
The Journal of Pharmacy and Pharmacology|April 28, 2023
Potential therapeutic role for pigment epithelium-derived factor in post-menopausal breast cancer bone metastasisNaomi Brook, Arun Dharmarajan, Arlene Chan, et al.
Asia-Pacific Journal of Clinical Oncology|June 28, 2021
Drug induced vitiligo-like depigmentation from a CDK 4/6 inhibitorOn B Chan, John C Su, Anousha Yazdabadi, et al.
ANZ Journal of Surgery|September 3, 2021
BreastSurgANZ members recommendations for adjuvant systemic treatment and patient compliance in Australian breast cancer patientsArlene Chan, Nicola O'Neil, Chris Lomma, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Drugs|February 21, 2009
Antiangiogenic therapy for metastatic breast cancer: current status and future directionsArlene Chan
Therapeutic Advances in Medical Oncology|September 2, 2016
Neratinib in HER-2-positive breast cancer: results to date and clinical usefulnessArlene Chan
European Journal of Cancer (Oxford, England : 1990)|May 26, 2009
Capecitabine and vinorelbine in metastatic breast cancerArlene Chan, Mark Verrill
Breast (Edinburgh, Scotland)|August 11, 2014
Utilisation of primary and secondary G-CSF prophylaxis enables maintenance of optimal dose delivery of standard adjuvant chemotherapy for early breast cancer: an analysis of 1655 patientsArlene Chan, Scott McGregor, Wenbin Liang
The Oncologist|September 15, 2006
The role of capecitabine in first-line treatment for patients with metastatic breast cancerKaren Gelmon, Arlene Chan, Nadia Harbeck
Clinical Breast Cancer|May 11, 2023
Adjuvant Dose Dense Chemotherapy in Patients With Obesity: Short-Term Toxicities and Breast Cancer OutcomeChris Lomma, HuiJun Chih, Arlene Chan
Cancer Medicine|February 8, 2023
Prognostic role of immune environment in luminal B early breast cancerArlene Chan, Jespal Gill, HuiJun Chih, et al.
The Journal of Pharmacy and Pharmacology|April 28, 2023
Potential therapeutic role for pigment epithelium-derived factor in post-menopausal breast cancer bone metastasisNaomi Brook, Arun Dharmarajan, Arlene Chan, et al.
Asia-Pacific Journal of Clinical Oncology|June 28, 2021
Drug induced vitiligo-like depigmentation from a CDK 4/6 inhibitorOn B Chan, John C Su, Anousha Yazdabadi, et al.
ANZ Journal of Surgery|September 3, 2021
BreastSurgANZ members recommendations for adjuvant systemic treatment and patient compliance in Australian breast cancer patientsArlene Chan, Nicola O'Neil, Chris Lomma, et al.
Pageof 9